We are privileged to share the acknowledgment that APICES has received in the recent publication titled: “Treatment patterns and intensification within 5 year of follow-up of the first-line anti-TNFα used for the treatment of IBD: Results from the VERNE study”, a study in which APICES has participated in study setup, design, monitoring, data management, statistics and preparation of the manuscript.
This means to all APICES team an extra motivation in order to give continuity to the implication we have in every project in which we collaborate. From APICES, we are pride because of the recognition of our work, and we want to thank Takeda Farmacéutica España S.A.for the opportunity they have given to APICES to appear in the acknowledgments section of the manuscript, and congratulate them and all the investigators for their project success.
This study assesses the treatment patterns with the first anti-TNFα in IBD.
You can find the publication in the following link:
Treatment patterns and intensification within 5 year of follow-up of the first-line anti-TNFα used for the treatment of IBD: Results from the VERNE study – Digestive and Liver Disease (dldjournalonline.com)